Test Price
2,800 AED✅ Home Collection Available
MITF Gene Melanoma Susceptibility – Genetic Test in UAE
Executive Summary & Core Metrics
Test Highlights
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation included.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This comprehensive NGS-based test sequences the entire MITF gene to identify pathogenic variants linked to cutaneous malignant melanoma susceptibility. The test uses next-generation sequencing to detect inherited mutations, empowering you and your physician with actionable genetic data for personalized prevention and surveillance.
| Feature | Our MITF NGS Test | Common Targeted Panel (Alternative) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – Full Gene | Sanger Sequencing / Limited Panels |
| Coverage | Complete coding region + splice sites | Selected hot‑spots only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often) |
| Price | 2800 AED | 2500–3500 AED (variable) |
Physician Insight & Safety Protocols
Note from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Reg. ID: 9294403):
“Genetic testing for melanoma susceptibility is a powerful risk‑stratification tool. A positive MITF variant indicates an inherited predisposition, not a guarantee of future cancer. With regular dermatological surveillance, sun protection, and lifestyle modifications, carriers can significantly reduce their melanoma risk. Always interpret results in consultation with a certified genetic counselor or oncologist.”
Advisory: Medication & Treatment Continuity
⚠️ Important Notice
Do not discontinue any prescribed medication without consulting your doctor. This genetic test assesses inherited risk; it does not replace ongoing treatment or surveillance for existing conditions.
Exclusion Criteria & Emergency Red Flags
🚫 Safety Exclusions
- Exclusion: Not intended for individuals under 18 without legal guardian consent and mandatory pre‑test genetic counselling.
- Exclusion: Not suitable as a stand‑alone diagnostic test for acute melanoma; it assesses inherited risk only.
- Emergency Red Flags: New, changing, or bleeding moles; sudden vision changes; severe unexplained pain—seek immediate medical attention (call 998 for UAE ambulance).
- ER Condition: If you experience a rapidly growing skin lesion, do not delay; visit the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What does the MITF gene melanoma test tell me?
Snippet: It identifies inherited mutations in the MITF gene that significantly raise your lifetime risk of developing cutaneous malignant melanoma.
The test uses next‑generation sequencing to detect pathogenic variants; results are classified as positive, negative, or variant of uncertain significance (VUS). A positive finding means you carry a known risk allele, enabling early surveillance and preventive strategies.
2. How is the sample collected and what preparation is required?
Snippet: A simple blood draw is all that’s needed—no fasting required. Our DHA‑certified phlebotomists perform home collection using a temperature‑controlled cold‑chain kit.
Prior to the test, you should provide a detailed family history of melanoma or other cancers. A pre‑test genetic counselling session (included) will chart your pedigree to ensure accurate interpretation.
3. Can this test predict if I will get melanoma?
Snippet: No test can predict with certainty; it stratifies your genetic risk to guide personalized prevention, not destiny.
Even with a high‑risk MITF variant, most carriers never develop melanoma if they follow sun safety and regular dermatological exams. This is a susceptibility assessment, not a diagnostic or prognostic tool for existing cancer.
UAE Regulatory & Data Privacy Adherence
Compliance & Accreditation
DHA Facility License No. 1143. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety measures follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is handled by DHA‑licensed clinical geneticists and remains strictly confidential.
Clinical & Logistical Metadata
| Test Name | MITF Gene Melanoma Susceptibility – Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA tube) via VIP Mobile Phlebotomy & Cold‑Chain Home Collection |
| Methodology Used | Next‑Generation Sequencing (NGS) – Whole Gene Analysis |
| ICD-10-CM Code | Z31.89 (Encounter for genetic testing for disease susceptibility) |
| LOINC Code | 55233-1 (MITF gene analysis) |
| DHA Facility License & Address | DHA License No. 1143 | DNA Labs UAE – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians